Sweden· SE-20190121000011
Parlodel 2,5 mg Tablett
A medicinal product containing bromocriptine mesilate, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Bromocriptine Mesilate
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- June 25, 2026
Packs & prices · 1
- se_varunummer20190121000011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bromocriptine mesilate in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBromocriptine 2.5mg tabletsNecessity Supplies Ltd
- United StatesBromocriptine mesylateSandoz Inc
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- PolandBromocornFarmaceutyczna Spółdzielnia Pracy FILOFARM
- NorwayParlodelMeda
- FinlandParlodelOrifarm Oy
- SwitzerlandParlodel, TablettenSandoz Pharmaceuticals AG
- NetherlandsParlodel 2,5 mg, tablettenMedical Valley Invest AB
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- France · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Netherlands · Parlodel
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07d70e1d-b9de-4976-87ca-3148000ec015 GET /v1/drugs/07d70e1d-b9de-4976-87ca-3148000ec015?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20190121000011",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190121000011",
"product_doc_link": "https://docetp.mpa.se/LMF/Parlodel%202.5%20mg%20tablet%20PT%20PL_09001bee807a71a9.pdf"
}See everything about bromocriptine mesilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.